Hills Bank & Trust’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$111K Buy
+795
New +$111K 0.01% 341
2025
Q2
Sell
-1,165
Closed -$131K 315
2025
Q1
$131K Buy
+1,165
New +$120K 0.01% 281
2017
Q3
Sell
-18,254
Closed -$1.29M 131
2017
Q2
$1.29M Sell
18,254
-148
-0.8% -$9.85K 0.42% 55
2017
Q1
$1.25M Sell
18,402
-261
-1% -$18.4K 0.42% 54
2016
Q4
$1.34M Sell
18,663
-430
-2% -$32K 0.47% 49
2016
Q3
$1.51M Buy
19,093
+10,185
+114% +$827K 0.55% 47
2016
Q2
$743K Buy
8,908
+1,378
+18% +$122K 0.27% 75
2016
Q1
$692K Buy
7,530
+1,240
+20% +$112K 0.26% 75
2015
Q4
$636K Buy
6,290
+3,480
+124% +$362K 0.24% 66
2015
Q3
$276K Buy
+2,810
New +$312K 0.11% 74

Other funds holding GILD

Hills Bank & Trust's GILD Position: Q1 2026 in Review

Hills Bank & Trust opened a new position in Gilead Sciences (GILD) in Q1 2026: 795 shares worth $111K. The stake represents 0.01% of the portfolio and ranks #341 among its holdings. This is a return to the name: Hills Bank & Trust previously reported a position in GILD as recently as Q1 2025.

Hills Bank & Trust first reported a position in GILD in Q3 2015 and has held it in 10 quarters since. The position peaked at $1.51M in Q3 2016. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Hills Bank & Trust held 795 shares of Gilead Sciences worth $111K as of Q1 2026.
  • Gilead Sciences was a new Hills Bank & Trust position in Q1 2026.
  • Gilead Sciences made up 0.01% of Hills Bank & Trust's portfolio in Q1 2026, its #341 holding.
  • Hills Bank & Trust first reported a position in Gilead Sciences in Q3 2015 and has held it in 10 quarters since.
  • Hills Bank & Trust's Gilead Sciences position peaked at $1.51M in Q3 2016.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Hills Bank & Trust's 13F filing for Q1 2026, filed 1 May 2026.